Isn't it ironic: better RBCs by blocking iron
- PMID: 35980684
- PMCID: PMC9389635
- DOI: 10.1182/blood.2022017209
Isn't it ironic: better RBCs by blocking iron
Conflict of interest statement
Conflict-of-interest disclosure: R.E.F. is a member of the Scientific Advisory Board of Silence Therapeutics and receives research funding from Ultragenyx. R.E.F. and N.L.P. serve as consultants for Protagonist Therapeutics.
Comment on
-
The oral ferroportin inhibitor vamifeport improves hemodynamics in a mouse model of sickle cell disease.Blood. 2022 Aug 18;140(7):769-781. doi: 10.1182/blood.2021014716. Blood. 2022. PMID: 35714304 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
